Once named opponents in the Supreme Court case that legalized same-sex marriage, now they're friends
COLUMBUS, Ohio (AP) — The case behind the U.S. Supreme Court ruling legalizing same-sex marriage nationwide a decade ago is known as Obergefell v. Hodges, but the two Ohio men whose names became that title weren't so at odds as it would seem, and are now friends.
One year after the Supreme Court's June 26, 2015, decision, lead plaintiff Jim Obergefell was at an event for an LGBTQ+ advocacy organization when its former director asked if he wanted to meet Rick Hodges, who'd been the title defendant in his capacity as state health director in Ohio, one of the states challenged for not allowing same-sex couples to marry.
'I don't know, you tell me. Do I want to meet Rick Hodges?" Obergefell recalls responding.
The two met for coffee in a hotel and hit it off.
Hodges said he wanted to meet Obergefell because he's an 'icon.' He said he remembers telling Obergefell something along the lines of: 'I don't know if congratulations are in order because this began with you losing your husband, but I'm glad you won and I've never been so happy to lose in my life.'
Obergefell and John Arthur, who brought the initial legal action, were longtime partners living in Cincinnati. After Arthur was diagnosed with ALS, or amyotrophic lateral sclerosis, in 2011, Obergefell became Arthur's caregiver as the incurable condition ravaged his health. They flew to Maryland to marry before Arthur died in 2013, and the legal battle began when they learned their union wouldn't be listed on the death certificate handled by the Ohio Department of Health.
Although Hodges' role as health director required him to defend the state, it didn't mean that his personal views aligned with the state's position.
'Personally, I was supportive of their efforts, as were some of the people who worked on the case for the state. Professionally, I had a job to do and I did it to the best of my ability," Hodges said.
In the months leading up to the court's decision, Hodges had gathered a group of Ohio lawyers to develop the paperwork needed to create the licensing system for judges to grant same-sex couples marriage licenses on the day of the decision if the Supreme Court ruled in their favor, said Obergefell's lead attorney in the case, Al Gerhardstein.
Gerhardstein said Obergefell and Hodge's friendship is unusual in a 'very positive and exemplary way.'
'We need more models like that as we struggle with difficult social issues," he said.
The duo said they see each other two to three times per year and have routinely spoken together at conferences and panels.
'It's funny, whenever we go into an event together, everybody claps for him and looks at me like I'm the prince of darkness until we're done, and then it's great," Hodges said.
They are seeing each other more often this year since it's the 10th anniversary of the decision. Recently, they saw each other at a symposium at Northern Kentucky University and at another event, sponsored by Equality Ohio, the same organization that first led to their introduction.
'I can't think of other cases where the plaintiff and the defendant are friends. They might exist, I don't know about them," Obergefell said. "But I'm really glad that Rick and I are friends.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
4 hours ago
FDA requires updated warning about rare heart risk with COVID shots
WASHINGTON -- WASHINGTON (AP) — The Food and Drug Administration said Wednesday it has expanded existing warnings on the two leading COVID-19 vaccines about a rare heart side effect mainly seen in young men. Myocarditis, a type of heart inflammation that is usually mild, emerged as a complication after the first shots became widely available in 2021. Prescribing information from both Pfizer and Moderna already advises doctors about the issue. In April, the FDA sent letters to both drugmakers asking them to update and expand the warnings to add more detail about the problem and to cover a larger group of patients. While the FDA can mandate label changes, the process is often more of a negotiation with companies. Specifically, the new warning lists the risk of myocarditis as 8 cases per 1 million people who got the 2023-2024 COVID shots between the ages of 6 months and 64 years old. The label also notes that the problem has been most common among males ages 12 to 24. The previous label said the problem mostly occurs in 12- to 17-year-olds. The FDA's labeling change appears to conflict with some prior findings of scientists elsewhere in the U.S. government. The Centers for Disease Control and Prevention previously concluded there was no increased risk of myocarditis detected in government vaccine injury databases for COVID-19 shots dating back to 2022. Officials also noted that cases tend to resolve quickly and are less severe than those associated with COVID-19 infection itself, which can also cause myocarditis. The FDA announcement came as new vaccine advisers appointed by Health Secretary Robert F. Kennedy Jr. met to debate the continuing use of COVID-19 vaccines for key groups, including pregnant women. It's the first meeting of the CDC advisory panel since Kennedy abruptly dismissed all 17 members of the group, naming a new panel that includes several members with a history of anti-vaccine statements. The FDA's label update is the latest step by officials working under Kennedy to restrict or undercut use of vaccines. FDA Commissioner Marty Makary and a top deputy recently restricted annual COVID-19 shots to seniors and other Americans at higher risk from the virus. They've also suggested seasonal tweaks to match the latest circulating virus strains are new products that require extra testing. Outside experts said the new warning is the wrong approach. 'They are right to suggest that we need to consider myocarditis risks associated with the vaccine, but what they propose is exactly the wrong solution,' said Dr. Robert Morris, a public health specialist at the University of Washington. 'We should be investigating who is prone to myocarditis to see if we can predict and mitigate that risk.' Makary and several other FDA officials gained prominence during the pandemic by suggesting the federal government exaggerated the benefits of COVID-19 boosters and downplayed serious side effects, including myocarditis. Before joining the government, Makary and two of his current FDA deputies wrote a 2022 paper that said mandating booster shots in young people would cause more vaccine-related injuries than prevented hospitalizations from COVID-19 infections. The conclusion contradicted that of many leading vaccine and public health experts at the time, including at the CDC. ___
Yahoo
4 hours ago
- Yahoo
FDA requires updated warning about rare heart risk with COVID shots
WASHINGTON (AP) — The Food and Drug Administration said Wednesday it has expanded existing warnings on the two leading COVID-19 vaccines about a rare heart side effect mainly seen in young men. Myocarditis, a type of heart inflammation that is usually mild, emerged as a complication after the first shots became widely available in 2021. Prescribing information from both Pfizer and Moderna already advises doctors about the issue. In April, the FDA sent letters to both drugmakers asking them to update and expand the warnings to add more detail about the problem and to cover a larger group of patients. While the FDA can mandate label changes, the process is often more of a negotiation with companies. Specifically, the new warning lists the risk of myocarditis as 8 cases per 1 million people who got the 2023-2024 COVID shots between the ages of 6 months and 64 years old. The label also notes that the problem has been most common among males ages 12 to 24. The previous label said the problem mostly occurs in 12- to 17-year-olds. The FDA's labeling change appears to conflict with some prior findings of scientists elsewhere in the U.S. government. The Centers for Disease Control and Prevention previously concluded there was no increased risk of myocarditis detected in government vaccine injury databases for COVID-19 shots dating back to 2022. Officials also noted that cases tend to resolve quickly and are less severe than those associated with COVID-19 infection itself, which can also cause myocarditis. The FDA announcement came as new vaccine advisers appointed by Health Secretary Robert F. Kennedy Jr. met to debate the continuing use of COVID-19 vaccines for key groups, including pregnant women. It's the first meeting of the CDC advisory panel since Kennedy abruptly dismissed all 17 members of the group, naming a new panel that includes several members with a history of anti-vaccine statements. The FDA's label update is the latest step by officials working under Kennedy to restrict or undercut use of vaccines. FDA Commissioner Marty Makary and a top deputy recently restricted annual COVID-19 shots to seniors and other Americans at higher risk from the virus. They've also suggested seasonal tweaks to match the latest circulating virus strains are new products that require extra testing. Outside experts said the new warning is the wrong approach. 'They are right to suggest that we need to consider myocarditis risks associated with the vaccine, but what they propose is exactly the wrong solution,' said Dr. Robert Morris, a public health specialist at the University of Washington. 'We should be investigating who is prone to myocarditis to see if we can predict and mitigate that risk.' Makary and several other FDA officials gained prominence during the pandemic by suggesting the federal government exaggerated the benefits of COVID-19 boosters and downplayed serious side effects, including myocarditis. Before joining the government, Makary and two of his current FDA deputies wrote a 2022 paper that said mandating booster shots in young people would cause more vaccine-related injuries than prevented hospitalizations from COVID-19 infections. The conclusion contradicted that of many leading vaccine and public health experts at the time, including at the CDC. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
San Francisco Chronicle
4 hours ago
- San Francisco Chronicle
NBA players seem to tear their Achilles more frequently nowadays. Why is that?
INDIANAPOLIS (AP) — Kevin Durant and Tyrese Haliburton entered their respective NBA Finals elimination games with strained right calves. Each wound up leaving early with torn right Achilles tendons. Durant, a perennial All-Star and the league's 2014 MVP, missed the whole next season as he recovered from the injury and now Haliburton, the Indiana Pacers' two-time All-Star, could face a similar fate. Predictable? Perhaps. Both knew the risks when they opted to chase a championship, and both wound up paying the price when their tendons gave out on pro basketball's biggest stage. 'There's no question you're at a higher risk of worsening an injury or another injury occurring because maybe your gait is off a little bit or the muscle firing isn't as good,' said Dr. Kevin Farmer, an orthopedic surgeon and chief of sports medicine at the University of Florida. 'To Tyrese's credit, maybe he wasn't as healthy as he wanted to be, but he was willing to go out there and try to perform to win that championship for the team. "He made a decision to take that risk, and I think there should be some credit there for trying.' Haliburton's injury reflects a new trend, though, one that has seen younger players become more susceptible to Achilles injuries that were traditionally more prevalent in athletes in their mid to late 30s and early 40s. Haliburton, 25, Boston Celtics All-Star Jayson Tatum, 27, and Milwaukee Bucks All-Star Damian Lillard, 34, all suffered Achilles injuries in the playoffs and each is expected to miss most if not all of next season. Farmer and Dr. James Borchers, president and CEO of the U.S. Council for Athletes Health and a longtime team physician for Ohio State football, have studied the changes. They attribute the increase in Achilles injuries to many factors from low-cut shoes to longer seasons to Fluoroquinolone, a class of antibiotics both acknowledge has been tied to ruptured tendons. Neither has examined Haliburton, Tatum or Lillard. But they believe the biggest factor may be younger athletes shedding the multi-sport label to specialize in a single sport year-round, creating more wear and tear on specific body parts, such as elbows and Achilles tendons, that are prone to break down based on workload. 'Athletes that are doing a a lot impact — so certainly jumping and putting a lot of stress across tendons — and those tendons over time can develop into micro damage and lead to weakening in the tendon,' Borchers said. 'I think there's a lot more activity that increases the risk of these types of injuries and it's the wear and tear. It's very rare we're going to look at an otherwise healthy tendon rupture just rupture because of an acute event." It's not conjecture, either. Multiple studies from Farmer's medical team at Florida have researched whether today's overuse injuries in baseball occur because players are throwing harder for longer periods. Farmer said he considers the Achilles tendon in basketball to be comparable to the elbow in baseball. 'Instead of athletes getting (Achilles injuries) in their 30s or 40s because of wear and tear, we're seeing it now early on because of the excessive stress they've developed their whole lives,' Farmer said. 'I really think we're going to find out at some point that the way we've changed (youth sports), the risk, is why we're seeing these younger athletes injured.' The image of Haliburton crashing to the ground and agonizingly slapping the court in frustration may wind up as the most indelible image out of this year's NBA Finals. But he's already said he doesn't regret playing, and, like Durant, he doesn't intend to let that moment become the defining moment of his career. Instead, he plans to follow the example of Durant and others in the ever-expanding world of players who have overcome serious injuries to continue playing elite ball. The good news for Haliburton: Medical technology is helping athletes make quicker, more thorough recoveries. While a standard timetable for a return from Achilles injuries remains about 12 months, some NFL players have made it back in as few as nine and in 2023, former New York Jets quarterback Aaron Rodgers tried to do the unthinkable by returning for a playoff run less than four months after tearing his Achilles. Rodgers might have tried it — had the Jets been in the playoff hunt. Nobody expects Haliburton, Tatum or Lillard to push it that quickly, especially in a sport where running and jumping are so essential. Even Indiana Pacers coach Rick Carlisle has said he doesn't expect Haliburton to play next season. Durant didn't return from his June 2019 injury until December 2020. And at least Haliburton and Tatum have one big advantage — age is on their side. 'The intensity and attention to rehabilitation is fantastic and you're also talking about world-class athletes who sometimes recover differently from average individuals,' Borchers said. 'We've seen some really amazing individuals come back from these injuries and with the expertise in rehab and recovery and the work they're putting in, it's pretty amazing to see them come back sooner than what the textbook might say. And there's a big difference between (age) 25 and 39 or 40." ___
